Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fixed-duration multidrug therapy in multibacillary leprosy

H Y Li1, L F Hu, P W Wu

  • 1Beijing Tropical Medicine Research Institute, China.

International Journal of Leprosy and Other Mycobacterial Diseases : Official Organ of the International Leprosy Association
|June 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Test of CP Symmetry in the Neutral Decays of Λ via J/ψ→ΛΛ[over ¯].

Physical review letters·2026
Same author

[Value of the CD177/CD10 ratio in neutrophils in predicting infection risk in burn patients and the establishment of its normal reference range].

Zhonghua shao shang yu chuang mian xiu fu za zhi·2026
Same author

Precise Measurement of the Chromoelectric Dipole Moment of the Charm Quark.

Physical review letters·2026
Same author

Precise Measurement of Matter-Antimatter Asymmetry with Entangled Hyperon-Antihyperon Pairs.

Physical review letters·2026
Same author

Observation of Λ[over ¯]p→K^{+}π^{+}π^{-}π^{0} and Λ[over ¯]p→K^{+}π^{+}π^{-}2π^{0}.

Physical review letters·2026
Same author

[Clinical characteristics of smoking asthma and efficacy of long-acting muscarinic antagonist in treating patients with smoking asthma].

Zhonghua yi xue za zhi·2026

Fixed-duration multidrug therapy (FD-MDT) shows high efficacy in multibacillary leprosy patients, with a low relapse rate of 0.08/100 person-years. Most patients achieved smear negativity, and new deformities were minimal during treatment.

Area of Science:

  • Medical Research
  • Infectious Diseases
  • Dermatology

Background:

  • Leprosy remains a significant public health concern, particularly the multibacillary (MB) form.
  • Fixed-duration multidrug therapy (FD-MDT) has been the standard treatment for leprosy.
  • Understanding long-term outcomes of FD-MDT is crucial for disease control.

Purpose of the Study:

  • To evaluate the long-term efficacy and safety of fixed-duration multidrug therapy (FD-MDT) in multibacillary (MB) leprosy patients.
  • To determine relapse rates and the development of deformities after FD-MDT completion.
  • To assess the impact of prior dapsone treatment on treatment outcomes.

Main Methods:

  • A cohort of 657 active MB leprosy patients received FD-MDT between 1985 and 1992.

Related Experiment Videos

  • Patients were followed for 5 years post-therapy.
  • Relapse rates, smear negativity conversion, reaction incidence, and deformity progression were recorded.

    • Main Results:

    • An overall relapse rate of 0.08 per 100 person-years was observed, with both relapses occurring in patients with prior dapsone exposure.
    • Excluding relapses, 99.4% of MB patients achieved smear negativity by year 6.
    • Reactions were most frequent in the first 6 months, decreasing to zero by year 4. New deformities occurred in only 1.8% of patients.

    Conclusions:

    • FD-MDT is highly effective in achieving sustained remission and smear negativity in MB leprosy patients.
    • The risk of relapse appears low, particularly for patients without prior dapsone treatment.
    • FD-MDT is associated with a low incidence of new or progressive deformities during treatment.